×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
QTTB – q32 bio inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
QTTB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/7
07:02 am
qttb
Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
11/7
06:59 am
qttb
Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Low
Report
Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11/5
06:59 am
qttb
Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference
Medium
Report
Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference
10/24
07:16 am
qttb
Q32 Bio Inc. (NASDAQ: QTTB) is now covered by analysts at Raymond James. They set a "strong-buy" rating and a $90.00 price target on the stock.
Low
Report
Q32 Bio Inc. (NASDAQ: QTTB) is now covered by analysts at Raymond James. They set a "strong-buy" rating and a $90.00 price target on the stock.
10/14
07:05 am
qttb
Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 [Yahoo! Finance]
Medium
Report
Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 [Yahoo! Finance]
10/14
06:59 am
qttb
Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024
Medium
Report
Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024
9/11
08:02 am
qttb
Q32 Bio Inc. (NASDAQ: QTTB) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $95.00 price target on the stock.
Low
Report
Q32 Bio Inc. (NASDAQ: QTTB) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $95.00 price target on the stock.
8/29
06:59 am
qttb
Q32 Bio to Participate in Upcoming September Investor Conferences
Medium
Report
Q32 Bio to Participate in Upcoming September Investor Conferences
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
05:46 pm
qttb
Form SC 13G/A Q32 Bio Inc. Filed by: 5AM Ventures IV, L.P.
Medium
Report
Form SC 13G/A Q32 Bio Inc. Filed by: 5AM Ventures IV, L.P.
11/13
04:06 pm
qttb
Form SC 13G Q32 Bio Inc. Filed by: BRISTOL MYERS SQUIBB CO
High
Report
Form SC 13G Q32 Bio Inc. Filed by: BRISTOL MYERS SQUIBB CO
11/7
07:19 am
qttb
Form 10-Q Q32 Bio Inc. For: Sep 30
Low
Report
Form 10-Q Q32 Bio Inc. For: Sep 30
11/7
07:05 am
qttb
Form 8-K Q32 Bio Inc. For: Nov 07
Low
Report
Form 8-K Q32 Bio Inc. For: Nov 07
10/25
06:06 am
qttb
Form SC 13G/A Q32 Bio Inc. Filed by: Temasek Holdings (Private) Ltd
Medium
Report
Form SC 13G/A Q32 Bio Inc. Filed by: Temasek Holdings (Private) Ltd
10/16
08:40 pm
qttb
Form 4 Q32 Bio Inc. For: Oct 11 Filed by: Violette Shelia M.
Low
Report
Form 4 Q32 Bio Inc. For: Oct 11 Filed by: Violette Shelia M.
10/10
04:05 pm
qttb
Form 4 Q32 Bio Inc. For: Oct 08 Filed by: Violette Shelia M.
Low
Report
Form 4 Q32 Bio Inc. For: Oct 08 Filed by: Violette Shelia M.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: